Astec LifeSciences Limited (NSE:ASTEC)
India
· Delayed Price · Currency is INR 700.40
-26.35 (-3.63%)
Apr 29, 2026, 3:29 PM IST
Astec LifeSciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2021 - 2017 |
| Market Capitalization | 16,194 | 12,046 | 13,243 | 20,932 | 27,154 | 34,391 | Upgrade
|
| Market Cap Growth | 13.18% | -9.04% | -36.73% | -22.91% | -21.04% | 74.99% | Upgrade
|
| Enterprise Value | 20,564 | 15,622 | 18,229 | 25,222 | 29,616 | 36,253 | Upgrade
|
| Last Close Price | 726.75 | 540.60 | 670.36 | 1059.72 | 1373.40 | 1739.29 | Upgrade
|
| PE Ratio | - | - | - | - | 106.22 | 38.27 | Upgrade
|
| PS Ratio | 3.57 | 2.66 | 3.47 | 4.56 | 4.32 | 5.08 | Upgrade
|
| PB Ratio | 4.14 | 3.08 | 5.64 | 5.67 | 6.47 | 8.67 | Upgrade
|
| P/TBV Ratio | 4.43 | 3.29 | 6.27 | 5.98 | 6.73 | 8.93 | Upgrade
|
| P/OCF Ratio | - | - | - | 204.79 | 36.37 | 145.70 | Upgrade
|
| EV/Sales Ratio | 4.54 | 3.45 | 4.78 | 5.50 | 4.71 | 5.36 | Upgrade
|
| EV/EBITDA Ratio | - | 2866.95 | - | - | 39.00 | 23.60 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 68.15 | 30.13 | Upgrade
|
| Debt / Equity Ratio | 1.15 | 1.15 | 2.36 | 1.34 | 0.81 | 0.70 | Upgrade
|
| Debt / EBITDA Ratio | 823.88 | 823.88 | - | - | 4.47 | 1.81 | Upgrade
|
| Net Debt / Equity Ratio | 1.12 | 1.12 | 2.36 | 1.34 | 0.81 | 0.70 | Upgrade
|
| Net Debt / EBITDA Ratio | 801.39 | 801.39 | -8.27 | -80.19 | 4.49 | 1.82 | Upgrade
|
| Net Debt / FCF Ratio | -5.06 | -5.06 | -18.33 | -3.94 | -8.00 | -3.47 | Upgrade
|
| Asset Turnover | 0.50 | 0.50 | 0.41 | 0.47 | 0.67 | 0.86 | Upgrade
|
| Inventory Turnover | 2.00 | 2.00 | 1.72 | 1.32 | 1.69 | 2.68 | Upgrade
|
| Quick Ratio | 0.52 | 0.52 | 0.41 | 0.43 | 0.30 | 0.57 | Upgrade
|
| Current Ratio | 0.89 | 0.89 | 0.93 | 1.00 | 0.95 | 1.05 | Upgrade
|
| Return on Equity (ROE) | -25.84% | -25.84% | -44.57% | -11.88% | 6.27% | 25.46% | Upgrade
|
| Return on Assets (ROA) | -3.04% | -3.04% | -7.40% | -2.66% | 2.90% | 9.55% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.55% | -5.49% | -13.31% | -5.13% | 4.43% | 15.24% | Upgrade
|
| Return on Capital Employed (ROCE) | -10.00% | -10.00% | -21.30% | -7.20% | 9.60% | 29.60% | Upgrade
|
| Earnings Yield | -5.00% | -6.72% | -10.18% | -2.24% | 0.94% | 2.61% | Upgrade
|
| FCF Yield | -5.33% | -7.16% | -2.28% | -5.99% | -1.57% | -2.34% | Upgrade
|
| Dividend Yield | - | - | - | 0.14% | 0.11% | 0.09% | Upgrade
|
| Payout Ratio | - | - | - | - | 11.50% | 3.27% | Upgrade
|
| Buyback Yield / Dilution | -9.18% | -9.18% | -0.01% | -0.02% | -0.04% | -0.05% | Upgrade
|
| Total Shareholder Return | -9.18% | -9.18% | -0.01% | 0.13% | 0.07% | 0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.